Results 1 to 10 of about 4,331 (50)

Complete and Rapid NMR Characterization of Therapeutic Monoclonal Antibodies via Differential Labeling of Fab Fragments in <i>Escherichia coli</i>. [PDF]

Anal Chem
Gagné D, Aubin Y.
europepmc   +1 more source

Rewiring Antitumor Immunity: Targeting CLDN18.2 with Conditional 4-1BB Activation. [PDF]

Clin Cancer Res
Pretelli G, Garralda E.
europepmc   +1 more source

Correction: The Evolution of Anti‑CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and Function. [PDF]

CNS Drugs
Cree BAC, Berger JR, Greenberg B.
europepmc   +1 more source

From Acute Carditis, Rheumatic Carditis, and Morphologic Cardiac Reactions to Allergic Angina, Allergic Myocardial Infarction, and Kounis Syndrome: A Multidisciplinary and Multisystem Disease. [PDF]

J Cardiovasc Dev Dis
Kounis NG, Stefanidis A, Hung MY, Özkan U, de Gregorio C, Ceasovschih A, Mplani V, Gogos C, Assimakopoulos SF, Chatzigrigoriadis C, Plotas P, Dousdampanis P, Kouni SN, Tsigkas G, Patsouras N, Calogiuri G, Pourmasumi S, Koniari I.   +17 more
europepmc   +1 more source

Advantages of MabSelect VH3, a novel VH3-specific Protein A resin, over its two conventional counterparts in purifying a VHH-based trispecific antibody. [PDF]

J Biol Methods
Fang D, Qi W, Li Y.
europepmc   +1 more source

Isolation of neutralizing antibodies against SARS-CoV-2 through an epitope-guided negative screening by phage display. [PDF]

J Biomed Res
Lu M, Chen Y, Liu X, Gao F, Gou L, Ye W, Wen J, Guo X, Gao W.   +8 more
europepmc   +1 more source

Vascular endothelial growth factor-A and drug level in serum and human breast milk of a lactating woman after intravitreal injection of ranibizumab: a case report. [PDF]

Front Med (Lausanne)
Zhang J, Niu B, Wang Y, Li Y, Wang Q, Xiao Y.   +5 more
europepmc   +1 more source

Expanding the horizons of cancer therapy with next-generation 4-1BB agonists: a review of molecular and clinical strategies to maximize efficacy and ensure safety. [PDF]

MAbs
You G, Choi J, Yang C, Kim S, Jeon J, Park K, Lee Y, Lee SH.   +7 more
europepmc   +1 more source

The tetravalent, bispecific properties of FS118, an anti-LAG-3/PD-L1 antibody, mediate LAG-3 shedding from CD4 + and CD8 + tumor-infiltrating lymphocytes. [PDF]

Anticancer Drugs
Reader CS, Liao W, Potter-Landua BJ, Veyssier CS, Seal CJ, Brewis N, Morrow M.   +6 more
europepmc   +1 more source

Engineered macrophages accumulate in solid tumors and locally deliver immune-activating proteins to inhibit tumor progression. [PDF]

Transl Cancer Res
Xu Y, Zhou Y, Wang J.
europepmc   +1 more source